↩ Go Back
Need help?

Biotechnology Businesses for Sale and Investment Opportunities in North America

Showing 1 - 5 of 5 Biotechnology Businesses for Sale and Investment Opportunities in North America. Buy or Invest in a Biotechnology, Agricultural Biotechnology, Biotech Facility, Biopharma, Bio Diagnostic, Bio Medical Device or a Bio Therapeutic Drug Business.

Filters
  • Biotechnology

  • North America

 

Bio Diagnostic Franchise Opportunity

Enbiosis Biotechnology, Established in 2021, 13 Franchisees, London Headquartered
  • 10+ introductions
  • 700+ Page Views
  • 200+ Investor Views
- Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.
Enbiosis Biotechnology, Established in 2021, 13 Franchisees, London Headquartered
9.5   Expanding in Canada
Exp Monthly Sales
USD 190 thousand
Space Required
0 - 80 Sq Ft
Investment Required
USD 60 K
Contact Company

Bio Diagnostics Company Investment Opportunity in Phoenix, United States

Gene therapy and biomarker/diagnostic company focused on neurological conditions including; ALS, Parkinson's, Alzheimer's and TBI.
- Business primarily focused on gene therapy and biomarker/diagnostic services, with a specific emphasis on neurological conditions such as ALS, Parkinson's, Alzheimer's, and TBI. - Offers biomarker testing as a CRO for pharma and researchers. Additionally, it is involved in the development of Adeno-Associated Viruses (AAVs) for neurodegenerative disorders, with a particular focus on inflammation and targeting neurons and glial cells. - Has patented and licensed technologies from premier research institutions. - The company generates revenue on a per research project basis, with an average project duration of 3 months and an average value ranging from $8,000 to $25,000. It has successfully completed projects for 10 different research companies since its inception. - The company is currently engaged in a gene therapy research project involving 2,600 samples. - There are 2 permanent employees, additionally, we have a few temporary employees/interns as well.
7.9   Phoenix
Run Rate Sales
USD 150 thousand
EBITDA Margin
Nil
Financial Investment
USD 20 Mn for 20%
Contact Business

Biotechnology Business Assets for Sale in Los Angeles, United States

Human cancer gene therapy microbiology technology for sale.
- We are a new type of biotech company dedicated to human cancer gene therapy and have been working on research projects and the development of human gene therapy vectors. - Our company has generated various types of DNA nanoparticles for cancer gene therapy. - Now we have developed new type of RNA nanoparticles called engineered cellular microvesicles (ECM), or RNA microvesicles. - These are purified cytomox/anti-cancer gene products, such as p16, p53, PTEN, CDC6 shRNA, purified ECM-RV/anti-cancer mRNA, such as p16, p53, CDC6 shRNA, GSDME, EZH2 shRNA, Klotho, etc. - The technology includes R&D for the above-mentioned particles and products. - The R&D & the technology are valued at USD 1 million. Additionally, USD 3-4 million will be required to complete the clinical trials, tests, and marketing. - The technology is ready and needs to undergo some tests and clinical trials. - We want to sell the technology and help the buyer to get it patented and market the technology.
Human cancer gene therapy microbiology technology for sale.
8.1   Los Angeles
Ownership Duration
10-20 year(s)
Industries
Biotechnology
Asset Sale
USD 1 Mn
Contact Business

Biotechnology Company Investment Opportunity in Tyngsborough, United States

Bio-technology company involved in nano-particle technology research and development in the bio-medical sector.
- A bio-technology research and development company based in Tyngsborough, Massachusetts. - We do R&D in nano-particle technology for the bio-medical research sector. - We license our technologies to other bio-medical companies, and companies belonging to the agriculture sector. - We collaborate with The National Institute of Health. - We are seeking funds to get one of the new research projects approved by FDA. - Physical assets include machines and equipment. The facility is rented.
Bio-technology company involved in nano-particle technology research and development in the bio-medical sector.
8.1   Tyngsborough
Run Rate Sales
USD 180 thousand
EBITDA Margin
0 - 10 %
Financial Investment
USD 375 K for 50%
Contact Business

Frequently
Asked
Questions

  • How many biotechnology businesses for sale and investment opportunities in North America are listed on SMERGERS?
    There are 5 active and verified biotechnology businesses for sale and investment opportunities in North America listed on SMERGERS as of 28 March 2024.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more